Münevver D.
- Country
- Germany
- Department
- Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie
Research Overview
- N1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Efimosfermin Alfa in Adults with Biopsy‑Confirmed F2–F3 Metabolic Dysfunction‑Associated Steatohepatitis
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Efimosfermin Alfa Safety and Tolerability in Adults with F2‑F3 Metabolic Dysfunction‑Associated Steatohepatitis
Data & Insights
Has run more than one trial at 180 of 344 partner sites.
Specializations
Liver Disease Management
The investigator specializes in treating various forms of liver conditions, with particular emphasis on non-alcoholic steatohepatitis (NASH) and primary sclerosing cholangitis (PSC). Their research extends to innovative therapeutic approaches for alcohol-related liver disease.
- NASH and Metabolic Dysfunction
- Primary Sclerosing Cholangitis
- Alcohol-Related Liver Disease
Their work encompasses liver fibrosis assessment and management strategies for cirrhotic conditions.
Hepatic Complications
The investigator focuses on addressing complex hepatic conditions, including hepatic encephalopathy and liver-related clinical outcomes. Their expertise includes managing pruritus associated with PSC.
- Hepatic Encephalopathy Management
- Liver Disease Complications
- Symptom Management in Liver Disease
Their research includes evaluating treatments for liver-related complications and associated symptoms.
Metabolic Health
The investigator studies the intersection of metabolic health and liver disease, with expertise in obesity-related liver conditions and metabolic dysfunction-associated steatohepatitis (MASH).
- Obesity Management
- Metabolic Liver Disease
- Weight-Related Complications
Their work includes investigating treatments that address both metabolic and hepatic aspects of disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.